Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Avience Biomedicals IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
Financial Information of Avience Boimedicals Limited IPO
The Revenues from operations for the Period ended on January 31, 2026, 2025 and 2024 were ₹ 4194.28 Lakh, ₹ 4596.74 Lakh, and ₹ 2437.27 Lakh, The EBITDA for the the Period ended on January 31, 2026, and Fiscals ended on Mar 31, 2025, and 2024 were ₹ 1033.53 Lakh, ₹ 1141 Lakh and ₹ 407.52 Lakh, The Profit after Tax for the Period ended on January 31 2026, and Fiscals ended on Mar 31, 2025 and 2024 were ₹ 573.96 Lakh, ₹ 733.18 Lakh, and ₹ 214.11 Lakh, respectively. This indicates a steady growth in financial performance.
Avience Biomedicals Limited Financial Information (Restated Consolidated)
Amount in (₹ in Lakh)
| Period Ended | Jan 31, 2026 | Mar 31, 2025 | Mar 31, 2024 |
|---|---|---|---|
| Reserve of Surplus | 2,448.54 | 1,874.59 | 292.64 |
| Total Assets | 6,607.20 | 5,652.46 | 3,465.08 |
| Total Borrowings | 2,672.61 | 2,215.82 | 1,513.07 |
| Fixed Assets | 1,446.16 | 1,299.44 | 1,011.78 |
| Cash | 100.98 | 419.98 | 14.57 |
| Cash flow from operating activities | 277.79 | 360.63 | 98.50 |
| Cash flows from investing activities | 903.53 | -880.59 | -402.77 |
| Cash flow from financing activities | 306.74 | 925.37 | 296.72 |
| Net Borrowing | 2,571.63 | 1,795.84 | 1,498.50 |
| Revenue | 4,194.28 | 4,596.74 | 2,437.27 |
| EBITDA | 1,033.53 | 1,141.00 | 407.52 |
| PAT | 573.96 | 723.18 | 214.11 |
| PAT Margin | 13.68% | 15.73% | 8.78% |
| EPS | 14.24 | 19.06 | 6.52 |
Note 1:- RoE, ROCE & RoNW calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Profit/Loss for the Year) on 31st Mar, 2025 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on Cap Price Post Issue Data, given in FINANCIAL EXPRESS.
